Related references
Note: Only part of the references are listed.Serum Visfatin, Fetuin-A, and Pentraxin 3 Levels in Patients With Psoriasis and Their Relation to Disease Severity
Gokhan Okan et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2016)
Cytokines in psoriasis
Jaymie Baliwag et al.
CYTOKINE (2015)
Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients
Luisa Costa et al.
CLINICAL RHEUMATOLOGY (2014)
Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review
Maurizio Pompili et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Hepatitis C virus infection enhances TNFα-induced cell death via suppression of NF-κB
Junseong Park et al.
HEPATOLOGY (2012)
Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study
V. Modesti et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2012)
Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients
F. Prignano et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Liver Diseases Associated with Anti-Tumor Necrosis Factor-alpha (TNF-alpha) Use for Inflammatory Bowel Disease
Carla S. Coffin et al.
INFLAMMATORY BOWEL DISEASES (2011)
Infliximab-related hepatitis: discussion of a case and review of the literature
Stefano Mancini et al.
INTERNAL AND EMERGENCY MEDICINE (2010)
Efficiency and Safety of Etanercept after Acute Hepatitis Induced by Infliximab for Psoriasis
Nicolas Kluger et al.
ACTA DERMATO-VENEREOLOGICA (2009)
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases
I. Cavazzana et al.
AUTOIMMUNITY REVIEWS (2008)
Changing epidemiology of HCV and HBV infections in northern Italy - A survey in the general population
Paolo Fabris et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Pathogenetic and clinical rationale for TNF-blocking therapy in psoriatic arthritis
Leonardo Punzi et al.
AUTOIMMUNITY REVIEWS (2007)
Combination therapy with cyclosporine A and anti-TNF-α agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection
Francesca Bellisai et al.
CLINICAL RHEUMATOLOGY (2007)
Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab
Angel M. Garcia Aparicio et al.
CLINICAL RHEUMATOLOGY (2007)
Inhibition of TNFα does not induce viral reactivation in patients with chronic hepatitis C infection:: two cases
S. Aslanidis et al.
CLINICAL RHEUMATOLOGY (2007)
Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis
S Wahie et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)
Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection
C Rokhsar et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: Guidelines for clinical approach
Debbie M. Nathan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Anti-tumour necrosis factor a therapy in rheumatoid arthritis: an update on safety
KL Hyrich et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Safety of tumour necrosis factor-alpha antagonists
D Khanna et al.
DRUG SAFETY (2004)
Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases
MA Magliocco et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn's disease:: A prospective cohort study
S Vermeire et al.
GASTROENTEROLOGY (2003)
Psoriasis - epidemiology and clinical spectrum
E Christophers
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2001)
The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis
G Yosipovitch et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
Share Paper
